Home|DSIJArticleDetail

Low PE Pharma Penny Stock Below 60 Rockets Over 10 Per Cent Today with Heavy Volume; Here’s Why!
Low PE Pharma Penny Stock Below 60 Rockets Over 10 Per Cent Today with Heavy Volume; Here’s Why!

Low PE Pharma Penny Stock Below 60 Rockets Over 10 Per Cent Today with Heavy Volume; Here’s Why!

The company has a market cap of over Rs 400 crore and the stock is up by 16.67 per cent from its 52-week low of Rs 49.20 per share.

DSIJ Intelligence-1 Article rating: 5.0

The company has a market cap of over Rs 400 crore and the stock is up by 16.67 per cent from its 52-week low of Rs 49.20 per share.

Promoters hold 65.99 per cent stake: Low PE pharma penny stock below Rs 60; Company announces significant global expansion and strategic integration
Promoters hold 65.99 per cent stake: Low PE pharma penny stock below Rs 60; Company announces significant global expansion and strategic integration

Promoters hold 65.99 per cent stake: Low PE pharma penny stock below Rs 60; Company announces significant global expansion and strategic integration

The company has a market cap of Rs 287 crore and the stock is up by 6 per cent from its 52-week low of Rs 49.20 per share.

DSIJ Intelligence-1 Article rating: 3.3

The shares of the company have a PE of 12x whereas the industry PE is 36x.

Low PE pharma penny stock below Rs 60 jumps 14.50 per cent after reporting turnaround net profit of Rs 25 crore in FY25
Low PE pharma penny stock below Rs 60 jumps 14.50 per cent after reporting turnaround net profit of Rs 25 crore in FY25

Low PE pharma penny stock below Rs 60 jumps 14.50 per cent after reporting turnaround net profit of Rs 25 crore in FY25

The company has a market cap of over Rs 300 crore and the stock is up by 16.34 per cent from its 52-week low of Rs 49.20 per share.

DSIJ Intelligence-1 Article rating: 3.4

The company has a market cap of over Rs 300 crore and the stock is up by 16.34 per cent from its 52-week low of Rs 49.20 per share.

46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why
46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why

46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why

The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share.

DSIJ Intelligence-1 Article rating: 5.0

The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share.

Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares
Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares

Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares

The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share.

DSIJ Intelligence-1 Article rating: 5.0

The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share.

1,700 per cent returns in this multibagger stock; Don’t miss action in this stock as Board announces stock split!
1,700 per cent returns in this multibagger stock; Don’t miss action in this stock as Board announces stock split!

1,700 per cent returns in this multibagger stock; Don’t miss action in this stock as Board announces stock split!

The stock is up by 45 per cent from its 52-week low and gave multibagger returns of over 1,700 per cent in 5 years.

DSIJ Intelligence-1 Article rating: 4.3

The shares of the company have a PE of 19x, an ROE of 32.2 per cent and an ROCE of 38.5 per cent.

DSIJ MINDSHARE

Mindshare28-Jun, 2025

Bonus and Spilt Shares29-Jun, 2025

Mindshare28-Jun, 2025

Mindshare28-Jun, 2025

Mindshare28-Jun, 2025

Knowledge

Personal Finance15-Jun, 2025

Knowledge30-May, 2025

MF15-May, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Policy | WhiteList